These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2155053)

  • 21. [The prognostic value of serum neuron specific enolase detection in small cell lung cancer].
    Jin B; Zhao L; Zhou C
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Dec; 24(12):722-4. PubMed ID: 11930699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer.
    Akoun GM; Scarna HM; Milleron BJ; Bénichou MP; Herman DP
    Chest; 1985 Jan; 87(1):39-43. PubMed ID: 2981171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
    Jørgensen LG; Osterlind K; Hansen HH; Cooper EH
    Br J Cancer; 1994 Oct; 70(4):759-61. PubMed ID: 7917935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer.
    Cooper EH; Splinter TA; Brown DA; Muers MF; Peake MD; Pearson SL
    Br J Cancer; 1985 Sep; 52(3):333-8. PubMed ID: 2994704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.
    Bonner JA; Sloan JA; Rowland KM; Klee GG; Kugler JW; Mailliard JA; Wiesenfeld M; Krook JE; Maksymiuk AW; Shaw EG; Marks RS; Perez EA
    Clin Cancer Res; 2000 Feb; 6(2):597-601. PubMed ID: 10690544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical value of measurement of serum creatine kinase BB and neuron specific enolase for small cell lung cancer].
    Zhou J; Xiong Q
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):90-3. PubMed ID: 7657349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC).
    Jørgensen LG; Osterlind K; Hansen HH; Cooper EH
    Br J Cancer; 1992 Sep; 66(3):594-8. PubMed ID: 1325829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of serum neuron-specific enolase as a predictor of relapse of small cell lung cancer.
    Nitta T; Fukuoka M; Masuda N; Kusunoki Y; Matsui K; Kudoh S; Hirashima T; Yana T; Ito K; Takada M
    Jpn J Clin Oncol; 1995 Oct; 25(5):179-83. PubMed ID: 7474404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.
    Wójcik E; Kulpa JK; Sas-Korczyńska B; Korzeniowski S; Jakubowicz J
    Anticancer Res; 2008; 28(5B):3027-33. PubMed ID: 19031951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum NSE, CEA, CT, CA 15-3 levels in human lung cancer.
    Nutini S; Cappelli G; Benucci A; Catalani C; Nozzoli F
    Int J Biol Markers; 1990; 5(4):198-202. PubMed ID: 1965544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
    Schneider J; Philipp M; Salewski L; Velcovsky HG
    Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuron-specific enolase (NSE) in the surveillance of small cell cancers. An evaluation of the prognostic information using Markov's model].
    Pujol JL; Boher JM; Grenier J; Quantin X; Saffont L; Daurès JP
    Rev Mal Respir; 1998 Sep; 15(4):519-25. PubMed ID: 9805763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between serum tumor marker levels and tumor proliferation in small cell lung cancer.
    Lehtinen M; Wigren T; Lehtinen T; Kallioniemi OP; Aine R; Aaran RK; Ojala A
    Tumour Biol; 1988; 9(6):287-92. PubMed ID: 2849799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic influence of serum neuron specific enolase in small cell lung cancer.
    Jørgensen LG; Osterlind K; Hansen HH; Cooper EH
    Br J Cancer; 1988 Dec; 58(6):805-7. PubMed ID: 2852029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of "neuron-specific enolase" as a tumor marker for small cell carcinoma of the lung.
    Güner G; Oktay G; Akkoçlu A; Karlikaya C
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):306S. PubMed ID: 8224452
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuron-specific enolase in small-cell carcinoma of the lung: the value of combined immunocytochemistry and serum determination.
    Esscher T; Bergh J; Steinholtz L; Nöu E; Nilsson K; Påhlman S
    Anticancer Res; 1989; 9(6):1717-20. PubMed ID: 2560624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer.
    Carney DN; Marangos PJ; Ihde DC; Bunn PA; Cohen MH; Minna JD; Gazdar AF
    Lancet; 1982 Mar; 1(8272):583-5. PubMed ID: 6121182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung.
    Johnson DH; Marangos PJ; Forbes JT; Hainsworth JD; Van Welch R; Hande KR; Greco FA
    Cancer Res; 1984 Nov; 44(11):5409-14. PubMed ID: 6091878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy.
    Quoix E; Purohit A; Faller-Beau M; Moreau L; Oster JP; Pauli G
    Lung Cancer; 2000 Nov; 30(2):127-34. PubMed ID: 11086206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of serum neuron-specific enolase as a tumor marker for carcinoma of the lung.
    Ariyoshi Y; Kato K; Ishiguro Y; Ota K; Sato T; Suchi T
    Gan; 1983 Apr; 74(2):219-25. PubMed ID: 6305752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.